Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Boyle

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Reviews. Drug Discovery|May 1, 2012
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabDavid L Lacey, William J Boyle, W Scott Simonet, et al.
Cancer Research|November 19, 2004
Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexiaKeith S Kwak, Xiaolan Zhou, Vered Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodiesPeter M Bowers, Robert A Horlick, Tamlyn Y Neben, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKLPaul J Kostenuik, Hung Q Nguyen, James McCabe, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Reviews. Drug Discovery|May 1, 2012
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabDavid L Lacey, William J Boyle, W Scott Simonet, et al.
Cancer Research|November 19, 2004
Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexiaKeith S Kwak, Xiaolan Zhou, Vered Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodiesPeter M Bowers, Robert A Horlick, Tamlyn Y Neben, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKLPaul J Kostenuik, Hung Q Nguyen, James McCabe, et al.
Pageof 2